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Background: Women of reproductive age are a group of particular concern as diabetes may affect their pregnancy
outcome as well as long-term morbidity and mortality. This study aimed to compare the clinical profiles and
glycemic control of reproductive and non-reproductive age women with type 2 diabetes (T2D) in primary care
settings, and to determine the associated factors of poor glycemic control in the reproductive age group women.
Methods: This was a cross-sectional study using cases reported by public primary care clinics to the Adult Diabetes
Control and Management registry from 1st January to 31st December 2009. All Malaysian women aged 18 years
old and above and diagnosed with T2D for at least 1 year were included in the analysis. The target for glycemic
control (HbA1c < 6.5%) is in accordance to the recommended national guidelines. Both univariate and multivariate
approaches of logistic regression were applied to determine whether reproductive age women have an association
with poor glycemic control.
Results: Data from a total of 30,427 women were analyzed and 21.8% (6,622) were of reproductive age. There were
12.5% of reproductive age women and 18.0% of non-reproductive age women that achieved glycemic control.
Reproductive age group women were associated with poorer glycemic control (OR = 1.5, 95% CI = 1.2-1.8). The risk
factors associated with poor glycemic control in the reproductive age women were being of Malay and Indian race,
longer duration of diabetes, patients on anti-diabetic agents, and those who had not achieved the target total
cholesterol and triglycerides.
Conclusion: Women with T2D have poor glycemic control, but being of reproductive age was associated with
even poorer control. Health care providers need to pay more attention to this group of patients especially for those
with risk factors. More aggressive therapeutic strategies to improve their cardiometabolic control and pregnancy
outcome are warranted.
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The number of people afflicted with diabetes is increas-
ing both in developing and developed countries with
higher prevalence in men than in women [1,2]. However,
there are more women with diabetes than men [2]; in
some countries, women are more affected, and have an
increased risk of cardiovascular diseases and mortality
[3-5]. Besides this, the incidence of diabetes is increasing
among the younger age groups in the developing coun-
tries, reflecting the parallel increase in the prevalence of
obesity and leading of a more sedentary lifestyle [2].
Malaysia is a country with multi-ethnic population. It
consists of 28.3 million population with 67.4%, Bumiputera
(Malays and indigenous); 24.6% Chinese; 7.3%, Indians and
0.7%, others [6]. In West Malaysia, the Malays are the
predominant ethnic group which constituted 63.1% of the
population. Women represent 48.4% of the population [6].
The prevalence of diabetes in Malaysia has increased from
8.3% in 1996 to 14.9% in 2006 for those aged 30 years old
and above [7]. The prevalence of diabetes among women
aged 18 years and above (11.3%) was comparable to men
(11.9%) [7]. As younger people become affected by dia-
betes, more women in the reproductive age group are also
becoming affected [8,9]. Type 2 diabetes (T2D) remains
the most common type of diabetes in this country [10].
Women of reproductive age and with diabetes require
special attention. Apart from being vulnerable to long-term
diabetes complications such as nephropathy, retinopathy,
and cardiovascular diseases [4,11]; they are susceptible to
high-risk pregnancy, which would affect both maternal and
fetal outcomes [8,9,12]. Pregnant women with diabetes
have an increased risk of developing pre-eclampsia, overt
nephropathy, and proliferative retinopathy [8]. In addition,
there are increased risks of an operative procedure as well
as post-partum hemorrhage [12].
Glycemic control is important in diabetes manage-
ment. A longitudinal study has shown the benefits of
intensive glycemic control in risk reduction of micro-
vascular and macrovascular complications and these bene-
fits were maintained for over a decade [13,14]. In addition,
for women in reproductive age group, optimum glycemic
control before and during pregnancy reduces the risks of
fetal complications such as congenital malformations,
macrosomia, perinatal mortality as well as risks of future
childhood obesity, glucose intolerance, and diabetes melli-
tus [15-18].
Some studies have reported that younger patients with
T2D were associated with poorer glycemic control
[19,20]. However, we are unable to find literature on this
among T2D women in the primary care setting. We would
like to know the status of glycemic control in the repro-
ductive age women compared to the non-reproductive age
women. Thus, the objective of this study was to compare
the clinical profiles and glycemic control of reproductiveand non-reproductive age women with T2D in the pri-
mary care settings, and to determine the associated factors
of poor glycemic control in the reproductive age group
women. It is hoped that the results will provide prelimin-
ary evidence on the extent of the problem in these women
in primary care and to better strategize health care plan-
ning for these patients.
Methods
Study design and population
This was a cross-sectional study of women with T2D
using the data from the Adult Diabetes Control and
Management (ADCM). It is a web-based diabetes regis-
try initiated in May 2008. A total of 70,889 T2D patients
aged 18 years and above from 303 public primary care
clinics and hospitals in Malaysia were registered by
December 2009. All the public health clinics and hospi-
tals that managed diabetes were invited to participate in
this registry. Participation in ADCM was voluntary for
the patients and the health centres. The patients were
informed of the on-going registry and opportunity to
opt out was provided. The details of the registry have
been described elsewhere [21,22].
For our study, we extracted data of 30,427 Malaysian
women with T2D from 282 public primary care clinics
seen between 1st January and 31st December 2009. All
patients included were women diagnosed with T2D for
at least 1 year and were on treatment (diet control, oral
anti-diabetic agents, and/or insulin), and on follow-up.
Women who were pregnant during the period of registry
entry were not registered at the outpatient clinics as they
were on follow-up with the antenatal clinics. The repro-
ductive age group of women was defined as women aged
15 to 49 years [23,24]. However, the registry only
recruited adult women 18 years old and above. Thus, we
defined women in the reproductive age group as those 18
to 49 years old and for women in the non-reproductive
age group as those 50 years old and above. This study
complied with the Declaration of Helsinki and the
Medical Research and also obtained approval from the
Medical Research Ethics Committee, Ministry of Health,
Malaysia (NMRR-08-12-1167).
Data collection
The details of this project’s methodology and data col-
lection have been described in previous studies [21,22].
The data extracted for analysis for this paper included
demographic data (age and race [Malay, Chinese, Asian
Indian, and indigenous Bumiputera]), duration of diabetes,
co-morbidity, blood pressure (BP), weight, height, body
mass index (BMI), waist circumference, treatment modal-
ities, diabetes complications, and laboratory assessments
[fasting blood glucose (FBG), glycosylated haemoglobin
(HbA1c), serum creatinine, albuminuria, microalbuminuria,
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lipoprotein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), and triglyceride (TG)]. Results of
clinical examination and laboratory assessments were
accepted only if they were performed within 12 months of
data collection. Imputation was not performed for missing
values and missing values were excluded from analysis.
Presence of co-morbidity was defined as the presence
of either concomitant hypertension or dyslipidemia or
both. Hypertension was diagnosed if systolic BP was
130 mmHg and above and/or diastolic BP was 80 mmHg
and above, persistently or those whose current treatment
comprised anti-hypertensive agents [25]. The diagnosis
of dyslipidemia was based on the presence of either one
or in combination with elevation of LDL-C, TG, and/or
reduction of HDL-C [26].
In this study, the outcome measure was control of
glycemia. All the treatment targets were defined ac-
cording to the Malaysian Clinical Practice Guideline on
Management of Type 2 Diabetes Mellitus [27]. Glycemic
control was achieved if the HbA1c <6.5%, and BP
was targeted if ≤130/80 mmHg. Body mass index
(BMI) was classified into underweight (< 18.5 kg/m2),
normal (18.5 – 22.9 kg/m2), pre-obese (23 – 27.4 kg/m2),
and obese (≥ 27.5 kg/m2), while the waist circumference
was targeted if <80 cm. The control for lipids was defined
as LDL-C ≤ 2.6 mmol/L, HDL-C ≥1.1 mmol/L, and
TG ≤ 1.7 mmol/L.
The diabetes complications evaluated in this study
included retinopathy, nephropathy, cerebrovascular dis-
ease/stroke (CVD), ischemic heart disease, and foot prob-
lems. The diagnosis of these complications was based on
symptoms, signs, laboratory and radiological evidence, as
well as treatment history made by the attending doctors at
the clinics.
Statistical analysis
Categorical variables were presented as frequency (n) and
percentage (%), and numerical variables were presented as
mean and standard deviation (SD) because the dataset
was large and normality is assumed. No imputation was
performed for missing data, therefore the denominator
used in the analysis varied for each variable.
To determine whether reproductive and non-reproduct-
ive age group women have an association with poor gly-
cemic control, both univariate and multivariate approaches
of logistic regression were applied. The hypothesis of this
model was to determine whether women in the reproduct-
ive group have a higher level of HbA1c compared to non-
reproductive group. Fifteen variables were controlled in the
analysis stage because these 15 variables were suspected as
confounders that could also contribute to HbA1c sta-
tus. In addition, the 15 confounders were confirmed
significant at univariate analysis stage. The 15 confounderswere ethnicity, duration of diabetes in years, treatment of
diabetes, self-monitoring of blood glucose, statuses of
BMI, blood pressure, foot problem, cerebrovascular dis-
ease, nephropathy, ischemic heart disease, concomitant
morbidity, LDL, HDL, total cholesterol, and total triglycer-
ide. Multivariate logistic regression was used to confirm
whether the reproductive group still has poorer control
after adjusting for all the remaining potential confounders.
To examine the risk factors that could contribute to
the outcome of poor control of HbA1c among women
in the reproductive age group, eight out of nine sig-
nificant contributing factors of poor control of HbA1c
for women were selected (race, BMI, blood pressure
status, duration of diabetes, management, concomitant
co-morbidity, total cholesterol, triglyceride status). We
excluded CVD status in the multivariate analysis as the
number was too small. There were 18 patients with
CVD in the reproductive group, but out of 18, eight did
not report their HbA1c; two patients had good control
of HbA1c and the other eight patients had poor control
of HbA1c. Therefore, we dropped CVD in the multivari-
ate analysis to avoid invalid result. All analyses were
carried out using PASW 18.0 (SPSS, Chicago, IL).
Results
There were 30,427 women who fulfilled our inclusion
criteria and they were included in the analysis, with
21.8% (6,622/30,427) in the reproductive age group. The
mean age for the reproductive age group women was
43.2 (SD 5.6) years (range 18–49 years) and the mean
age for the non-reproductive age group women was 62.0
(SD 8.3) years (range 50–104 years). There was higher
proportion of Indian women (21.2%) in the reproductive
age group than in the non-reproductive age group
women (17.1%). There was higher proportion of repro-
ductive age women with duration of diabetes for less
than 5 years. A smaller proportion of women of repro-
ductive age reported co-morbidities of hypertension and
dyslipidemia as well as diabetes complications. The
demographic and clinical characteristics are summarized
in Table 1.
There was higher proportion of reproductive age
women who were obese. Furthermore, significantly fewer
women of reproductive age achieved the targets of
HbA1c, FBG, HDL-C, and waist circumference compared
to non-reproductive age women. Almost 70% to 80% of
the women (reproductive and non- reproductive age) did
not achieve the target for most of the clinical parameters
except for TG and HDL-C (Table 2). The majority of
diabetic women (both group) used oral anti-diabetic
agents and only about 10% were on insulin (alone and in
combination) (Table 3).
In examining the risk factors towards the poor control
of HbA1c of patients with T2D among women, the
Table 1 Demographic, complications and co-morbidity













<5 years 4115 (62.1) 10325 (43.4)
5 – 10 years 2103 (31.8) 9600 (40.3)
>10 years 404 (6.1) 3880 (16.3)
Race (n= 30417) <0.001
Malay 4597 (69.4) 14893 (62.5)
Chinese 561 (8.5) 4663 (19.6)
Indian 1402 (21.2) 4058 (17.1)
Others 59 (0.9) 184 (0.8)
Complications
Retinopathy (n= 18678) <0.001
Yes 203 (4.8) 1387 (9.6)




Yes 66 (1.4) 878 (5.1)




Yes 18 (0.3) 213 (1.2)




Yes 412 (8.4) 1886 (10.9)




Yes 170 (3.2) 948 (5.1)




No 1878 (28.4) 2686 (11.3)
Hypertension only 1766 (26.6) 7322 (30.7)
Dyslipidemia only 947 (14.3) 1919 (8.1)
Both 2031 (30.7) 11878 (49.9)
awomen aged 18 to 49 years, bwomen aged 50 and above, cReported in
mean (SD).
Table 2 Clinical parameters of women with T2D in the






BMI category (n=28670) <0.001
Normal 553 (8.8) 3929 (17.6)
Underweight 58 (0.9) 409 (1.8)
Pre-obese 2043 (32.4) 8399 (37.5)
Obese 3648 (57.9) 9631 (43.1)
Waist circumferencec
(n= 14276)




Achieved 475 (15.3) 1900 (17.0)




Achieved 1895 (29.1) 5263 (22.5)
Not achieved 4620 (70.9) 18107 (77.5)
HbA1cc
(n=20434)
8.83 (2.21) 8.29 (2.16) <0.001
HbA1c status (n=20434) <0.001
Achieved 550 (12.5) 2890 (18.0)
Not achieved 3862 (87.5) 13132 (82.0)
Fasting blood glucosec
(n=20188)




Achieved 719 (16.3) 3843 (24.3)
Not achieved 3685 (83.7) 11941 (75.7)
Total cholesterolc
(n=24983)




Achieved 2896 (53.4) 10199 (52.7)
Not achieved 2527 (46.6) 9145 (47.3)
HDLc (n=21466) 1.30 (0.51) 1.36 (0.51) <0.001
HDL status (n= 21466) <0.001
Achieved 3255 (69.4) 12730 (75.9)
Not achieved 1413 (30.6) 4048 (24.1)
LDLc (n=21275) 3.21 (1.05) 3.25 (1.11) 0.017
LDL status (n=21275) 0.391
Achieved 1335 (28.7) 4882 (29.4)
Not achieved 3314 (71.3) 11744 (70.6)
awomen aged 18 to 49 years, bwomen aged 50 and above, cReported in
mean (SD).
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other 15 confounders showed that age group was still
found to be significant. The reproductive age group
women was 1.5 times (OR = 1.5, 95% CI = 1.2- 1.8) morelikely to be associated with poor control of HbA1c
compared with the non-reproductive group.
Further analysis showed that risk factors associated with
poor glycemic control in the reproductive age women
Table 3 Management of diabetes for women with T2D in









Diet only 90 (1.4) 277 (1.2)
Oral ADA only 5559 (85.4) 20093 (86.0)
Insulin only 173 (2.6) 518 (2.2)




1 2099 (58.6) 7971 (43.4)
2 1053 (29.4) 6516 (35.5)




Statin only 2448 (89.3) 11857 (92.1)
Fibrate only 259 (9.4) 901 (7.0)




Yes 248 (9.6) 928 (10.1)
No 2325 (90.4) 8255 (89.9)
awomen aged 18 to 49 years, bwomen aged 50 and above, #Refer to any
combination of statin, fibrate and others, ADA = anti-diabetic agents.
Table 4 Factors associated with poor glycemic control
(HbA1c ≥6.5%) among reproductive age women with T2D
OR 95% CI P - value
Race 0.001
Chinese ref
Malay 1.600 1.152, 2.223 0.005
Indian 1.936 1.320, 2.839 0.001
Others 0.756 0.346, 1.652 0.483
Duration of DM <0.001
<5 years ref
5 – 10 years 1.567 1.250, 1.965 <0.001
>10 years 4.017 1.928, 8.369 <0.001
Treatment of diabetes <0.001
Diet only ref
Oral anti-diabetic agents only 8.103 3.777, 17.382 <0.001
Insulin only 18.891 5.774, 61.808 <0.001
Both oral and insulin 46.202 17.204,124.007 <0.001
Total cholesterol
Not achieved 1.291 1.040, 1.603 0.020
Achieved ref
Triglyceride status
Not achieved 1.788 1.453, 2.199 <0.001
Achieved ref
Control for race, BMI, blood pressure status, duration of diabetes, management,
concomitant co-morbidity, total cholesterol, triglyceride status.
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of diabetes, patients on anti-diabetic agents, and those
who had not achieved the target of total cholesterol and
triglycerides (Table 4).
Discussions
In this study, it is shown that one-fifth of women with
T2D were in the reproductive age group. This would
contribute to a significant health care concern. Thus, the
health care system needs to strategize the healthcare
planning to be able to cater to their special needs and
concerns.
According to the position statement of American
Diabetes Association and the European Association for
the Study of Diabetes, the reproductive age group
women require more stringent glycemic control in view
of younger age, longer life expectancy, shorter duration
of the disease, and lesser co-morbidities and complica-
tions [28]. However, this study showed that these women
had poorer glycemic control despite majority of them
having diabetes for less than 5 years and without com-
plications. After controlling for all the potential con-
founders, being in the reproductive age group remained
a significant factor for poor glycemic control.
The social expectation of women of reproductive age
is to procreate and have a family, regardless of theirmedical condition. Therefore, measures need to be taken
for reproductive age women with diabetes to achieve
good glycemic control before and during pregnancy to
improve the outcome of that pregnancy [29]. The modi-
fiable risk factors associated with poor glycemic control
identified in this study were patients on anti-diabetic
agents and those who had not achieved the target level
of total cholesterol and triglycerides. Multivariate logistic
regression showed that those with existing extensive
treatment with combination of insulin and oral anti-
diabetic agents were found to have poorer glycemic
control. This was most probably due to confounding by
indication (i.e. they were on these agents due to poor
control). Another reason could be late initiation of
insulin at a later stage of disease when glycemic control
became difficult. Thus, use of insulin is the result of
poor glycemic control. Furthermore, a study has shown
that there were delays in treatment intensification with
oral anti-diabetic agents and insulin in people with T2D
despite suboptimal glycemic control [30]. Hence, more
aggressive management such as early initiation of insulin
and intensified oral treatment is needed. This should
occur early after the diagnosis was made as a study
showed that achieving early and intensive glycemic
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function for at least 3.5 years [31].
Our results showed that a high proportion (71.6%) of
women of reproductive age with diabetes had concomitant
hypertension, dyslipidemia or both. They had poorer
metabolic control in most of the clinical parameters such
as HbA1c, FBG, HDL-C and LDL-C and waist circumfer-
ence. Furthermore, those who had not achieved the target
level of total cholesterol and triglycerides were at risk of
poor glycemic control. Socio-cultural behavior such as
dietary habits and lifestyle play an important role in the
glycemic and lipid control. Some of the barriers reported
in the literature for management of diabetic women dur-
ing pregnancy included difficulty of maintaining a healthy
diet and regular exercise, lack of social support and
barriers for insulin injection and home sugar monitoring
[32]. Further studies are needed to explore the barriers
and difficulties faced by women of reproductive age with
T2D in local settings to address their concerns.
Preconception, prepregnancy, and contraceptive care
are of utmost importance for a good pregnancy outcome
and improvement of women’s quality of life [33-35]. The
treatment of diabetes in women, especially in those of
reproductive age, requires special consideration. The
choice of anti-diabetic agents’ use must consider pos-
sible outcomes on fertility, interactions with hormonal
contraception, fetal health, breastfeeding, and bone
health [9,36,37].
Strength and limitations
The strength of this study is the data from the public
primary care clinics, which serves the majority of
patients with T2D in this country [38]. In addition, the
data were extracted from the nationwide registry which
was real-life practice data that reduced selection bias.
Although the sample might not cover all women in
Malaysia with T2D, this result could be generalized to
the care of women with T2D in primary care setting in
this country due to its large sample size. A previous
study found that when the sample size reached at least
500, the statistics analyzed from the sample are likely
the same with the parameters in that particular popula-
tion [39].
Among the limitations of this study were those inher-
ent to studies using secondary data. Missing values in
certain variables might affect the true associations of the
results. Also given the fact that this was a cross-sectional
study, therefore, the causal-effect relationship between
poor glycemic control and its predictors cannot be truly
established. Other factors include compliance, usage
of hormonal pills (oral contraceptive pills, hormone
replacement therapy), and the competency of the primary
care physician that were not captured and could have an
effect on the results.Conclusions
Women of reproductive age with T2D were associated with
poorer glycemic control compared to non-reproductive
age women. The risk factors associated with poor glycemic
control in the reproductive age women were being of
Malay and Indian race, longer duration of diabetes,
patients on anti-diabetic agents, and those who had
not achieved the target total cholesterol and triglycerides.
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